An Overview of Pharmaceutical Excipients: Safe or Not Safe?

被引:84
作者
Abrantes, Catia G. [1 ]
Duarte, Dinah [1 ]
Reis, Catarina P. [1 ,2 ,3 ]
机构
[1] Univ Lusofona Humanidades & Tecnol, Sch Sci & Hlth Technol, Lisbon, Portugal
[2] Univ Lusofona Humanidades & Tecnol, CBIOS Res Ctr Biosci & Hlth Technol, Lisbon, Portugal
[3] Univ Lisbon, Fac Sci, Biophys & Biomed Engn, IBEB, Lisbon, Portugal
关键词
excipients; toxicology; drug interactions; pre-formulation; stability; solid dosage form; DIFFERENTIAL SCANNING CALORIMETRY; IN-VITRO CHARACTERIZATION; OXIDATIVE-DEGRADATION; MAILLARD REACTION; DELIVERY-SYSTEM; DRUG; COMPATIBILITY; HYDROCHLORIDE; FORMULATION; CYCLODEXTRINS;
D O I
10.1016/j.xphs.2016.03.019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A medicine consists of 2 fundamental parts: the active pharmaceutical ingredient and the excipient. Most, if not all, medicines could not be made without the use of excipients. In the early times, the safety of excipients was overlooked and no specific safety tests were generally conducted. This fact has been changed over times and is currently being recognized that the excipient's toxicity is not negligible, because its direct interaction with the active pharmaceutical ingredient or between other excipients may occur, leading to a potential change in the relationship between effectiveness and toxicity. This review is intended to address the general status of the pharmaceutical excipients and to describe the safety assessment. As a summary, this review suggests the interest of simplifying the formulations as much as possible and the interest of reducing the number of excipients necessary to strictly meet the required functions. The risk/benefit ratio of an excipient should be always evaluated on the basis of not only its production and quality but also of its safety. Further research according to Good Manufacturing Practices, Guiding Principles in Toxicology Assessment, Good Laboratory Practices, and Good Distribution Practices requirements are needed and are fundamental for health safety, contributing to a comprehensive picture of this matter. (C) 2016 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:2019 / 2026
页数:8
相关论文
共 122 条
  • [1] Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipients
    Abdellah, Abubaker
    Noordin, Mohamed Ibrahim
    Ismail, Wan Azman Wan
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2015, 23 (01) : 9 - 13
  • [2] Agency EM, 2008, CPMPQWP41903 AG EM, P1
  • [3] Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients
    Amharar, Youness
    Curtin, Vincent
    Gallagher, Kieran H.
    O'Siochru, Eoin
    O'Connell, Peter
    Healy, Anne-Marie
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 81 : 181 - 188
  • [4] [Anonymous], 2004, La gouvernance au-dela des frontieres, document de reflexion, P1
  • [5] [Anonymous], 1997, PROC S TAEJON REPUBL
  • [6] [Anonymous], 2003, Guidance for Industry Q1A (R2) Stability Testing of New Drug Substances and Products
  • [7] [Anonymous], IMP NEW DRUG PROD Q3
  • [8] [Anonymous], 2006, JOINT IPEC PQG GOOD
  • [9] [Anonymous], USP NF REV B
  • [10] Ashok K, 2006, EXCIPIENT DEV PHARM, P127